Non-apoptotic cell death in malignant tumor cells and natural compounds

Cancer Lett. 2018 Apr 28:420:210-227. doi: 10.1016/j.canlet.2018.01.061. Epub 2018 Feb 1.

Abstract

Traditional cancer therapy is mainly targeting on enhancing cell apoptosis, however, it is well established that many cancer cells are chemo-resistant and defective in apoptosis induction. Therefore, it may have important therapeutic implications to exploit some novel natural compounds based on non-apoptotic programmed cell death. Currently, accumulating evidence shows that the compounds from nature source can induce non-apoptotic programmed cell death in cancer cells, and therefore these natural compounds have gained a great promise for the future anticancer therapeutics. In this review, we will concentrate our efforts on the latest developments regarding major forms of non-apoptotic programmed cell death--autophagic cell death, necroptosis, ferroptosis, pyroptosis, glutamoptosis and exosome-associated cell death. Our increased understanding of the role of natural compounds in regulating non-apoptotic programmed cell death will hopefully provide prospective strategies for cancer therapy.

Keywords: Cancer; Natural compounds; Non-apoptotic cell death.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Biological Products / chemistry
  • Biological Products / pharmacology*
  • Biological Products / therapeutic use
  • Cell Death
  • Cell Line, Tumor
  • Exosomes / drug effects
  • Exosomes / metabolism
  • Humans
  • Neoplasms / drug therapy
  • Neoplasms / metabolism*

Substances

  • Biological Products